E. B. Dalgaard

Molecular markers of skeletal muscle hypertrophy following 10 weeks of resistance training in oral contraceptive users and non-users.

N. Ørtenblad, M. Hansen, Mikkel Oxfeldt, 2020, Journal of applied physiology.

Influence of Second Generation Oral Contraceptive Use on Adaptations to Resistance Training in Young Untrained Women

S. Ringgaard, M. Hansen, Mikkel Oxfeldt, 2020, Journal of strength and conditioning research.

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

A. Loft, I. Hansen, F. Mehnert, 2018, Annals of the rheumatic diseases.

A Novel AQP2 Sequence Variant Causing Aquaporin-2 Retention in the Cytoplasm and Autosomal Dominant Nephrogenic Diabetes Insipidus

E. Klussmann, J. Hertz, B. Jensen, 2022, Kidney international reports.

One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept: – an Observational Study from the Danish Danbio Registry

A. Loft, I. Hansen, B. Glintborg, 2017 .

FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

B. Glintborg, M. Hetland, S. Chrysidis, 2017 .